Thoughts on Antibacterial and Antimicrobial Central Line Devices
JUL 19, 2016 | CONTAGION EDITORIAL STAFF
Michael Calderwood, MD, MPH, previously assistant hospital epidemiologist and associate director of antimicrobial stewardship at Brigham and Women’s Hospital, discusses concerns over antibacterial and antimicrobial central line devices.
Interview Transcript (slightly modified for readability)
“The evidence [regarding the use of antibacterial and antimicrobial central line devices] is still [in its early stages]. We know that [the devices] are in use, and sometimes hospitals will use them for certain devices but not others, just because that’s the way it works via purchasing.
My concerns, as a steward, is whether or not this is going to drive higher rates of resistance and I’m waiting for some better evidence on whether this should be standard practice.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Influenza A (H3N2) has caused most of the illnesses in this severe flu season, but influenza B is becoming increasingly responsible for more infections as the flu season continues to hit the United States.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512